Kelly, CP, et al.
Clostridium difficile colitis. New England Journal of Medicine
1994; 330: 257–262.
Olson, MM, et al.
Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982–1991. Infection Control and Hospital Epidemiology
1994; 15: 371–381.
Martinez, FJ, et al.
Clostridium difficile outbreaks: prevention and treatment strategies. Risk Management and Healthcare Policy
2012; 5: 55–64.
Akerlund, T, et al.
Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. Journal of Clinical Microbiology
2006; 44: 353–358.
Warny, M, et al.
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. The Lancet
2005; 366: 1079–1084.
Labbe, A-C, et al.
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrobial Agents and Chemotherapy
2008; 52: 3180–3187.
Bacci, S, et al.
Binary toxin and death after Clostridium difficile infection. Emerging Infectious Diseases
2011; 17: 976–982.
Walker, AS, et al.
Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clinical Infectious Diseases
2013; 56: 1589–1600.
Centers for Disease Control and Prevention (CDC). Vital signs: preventing Clostridium difficile infections. MMWR Morbidity and Mortality Weekly Report
2012; 61: 157–162.
Bauer, MP, et al.
Clostridium difficile infection in Europe: a hospital-based survey. The Lancet
2010; 377: 63–73.
St-Martin, G, et al.
Clostridium difficile. Statens Serum Institut EPI-NEWS; 25 March: No. 13-2009.
Olsen, KEP. Clostridium difficile 2009–2011. Statens Serum Institut EPI-NEWS; 22 February: No 7-8-2012.
Eyre, DW, et al.
Diverse sources of C. difficile infection identified on whole-genome sequencing. The New England Journal of Medicine
Kola, A, et al.
Survey of Clostridium difficile infection surveillance systems in Europe, 2011. Eurosurveillance
Dubberke, ER, et al.
Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilities. Infection Control and Hospital Epidemiology
2012; 33: 305–308.
Bager, P, et al.
Cesarean delivery and risk of intestinal bacterial infection. The Journal of Infectious Diseases
2010; 201: 898–902.
Voldstedlund, M, et al.
The Danish Microbiology Database (MiBa) 2010 to 2013. Eurosurveillance
Pedersen, CB, et al.
The Danish Civil Registration System. A cohort of eight million persons. Danish Medical Bulletin
2006; 53: 441–449.
European Centre for Disease Prevention and Control. European Surveillance of Clostridium difficile infections. Surveillance protocol version 22, 2015.
Larson, HE, et al.
Epidemiology of Clostridium difficile in infants. Journal of Infectious Diseases
1982; 146: 727–733.
Hall, IC, O'Toole, E. Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, bacillus difficilis. American Journal of Diseases of Children
1935; 49: 390–402.
Collignon, A, et al.
Heterogeneity of Clostridium difficile isolates from infants. European Journal of Pediatrics
1993; 152: 319–322.
Clostridium difficile in children: to treat or not to treat?
Pediatric Gastroenterology, Hepatology & Nutrition
2014; 17: 80–84.
Benoit, SR, et al.
Automated surveillance of Clostridium difficile infections using BioSense. Infection Control and Hospital Epidemiology
2011; 32: 26–33.
Gubbels, S, et al. HAIBA - Hospital-Acquired Infection database. Statens Serum Institut EPI-NEWS; 25 February: No 9-2015.
Banks, A-L, et al. National study of outcome after Clostridium difficile infection (CDI) in Scotland. Information services division Scotland.